The predictive value of DKI in breast cancer: Does tumour subtype affect pathological response evaluations?

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations · Full text

Medicine, Oncology, Pathology +11

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Kimberly H. Allison, M. Elizabeth H. Hammond, Mitch Dowsett et al. · Journal of Clinical Oncology · 2020 · 1.5K citations · Full text

Medicine, Endocrinology, Oncology +17

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival

Keith N. Ogston, Iain D. Miller, Simon Payne et al. · The Breast · 2003 · 994 citations · Full text

Medicine, Oncology, Pathology +17

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

Peter A. Fasching, Katharina Heusinger, Lothar Haeberle et al. · BMC Cancer · 2011 · 328 citations · Full text

Medicine, Cancer Biology, Oncology +16

Prostate Cancer: Feasibility and Preliminary Experience of a Diffusional Kurtosis Model for Detection and Assessment of Aggressiveness of Peripheral Zone Cancer

Andrew B. Rosenkrantz, Eric E. Sigmund, Glyn Johnson et al. · Radiology · 2012 · 245 citations

Medicine, Radiology, Urology +17